Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Feb 1;64(3):364-367.
doi: 10.1093/cid/ciw745. Epub 2016 Nov 10.

Increased Antiviral Treatment Among Hospitalized Children and Adults With Laboratory-Confirmed Influenza, 2010-2015

Grace D Appiah  1   2 , Sandra S Chaves  3 , Pam D Kirley  2 , Lisa Miller  4 , James Meek  5 , Evan Anderson  6 , Oluwakemi Oni  7 , Patricia Ryan  8 , Seth Eckel  9 , Ruth Lynfield  10 , Marisa Bargsten  11 , Shelley M Zansky  12 , Nancy Bennett  3 , Krista Lung  13 , Christie McDonald-Hamm  14 , Ann Thomas  15 , Diane Brady  16 , Mary L Lindegren  17 , William Schaffner  17 , Mary Hill  18 , Shikha Garg  3 , Alicia M Fry  3 , Angela P Campbell  19
Affiliations

Increased Antiviral Treatment Among Hospitalized Children and Adults With Laboratory-Confirmed Influenza, 2010-2015

Grace D Appiah et al. Clin Infect Dis. .

Abstract

(See the Editorial Commentary by Martin on pages 368-9.)Using population-based surveillance data, we analyzed antiviral treatment among hospitalized patients with laboratory-confirmed influenza. Treatment increased after the influenza A(H1N1) 2009 pandemic from 72% in 2010-2011 to 89% in 2014-2015 (P < .001). Overall, treatment was higher in adults (86%) than in children (72%); only 56% of cases received antivirals on the day of admission.

Keywords: antiviral; influenza; oseltamivir..

PubMed Disclaimer

Conflict of interest statement

Potential conflicts of interest

All authors: No reported conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

Figures

Figure 1
Figure 1
Antiviral treatment in patients hospitalized with laboratory-confirmed influenza, by age group and influenza season, 2010–2011 to 2014–2015 (n = 43 708). Test for trend across the 5 seasons was significant in all age groups (P < .001).
See this image and copyright information in PMC

Comment in

References

    1. Dobson J, Whitley RJ, Pocock S, Monto AS. Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials. Lancet. 2015;385:1729–37. - PubMed
    1. Lipsitch M, Hernán MA. Oseltamivir effect on antibiotic-treated lower respiratory tract complications in virologically positive randomized trial participants. Clin Infect Dis. 2013;57:1368–9. - PMC - PubMed
    1. Louie JK, Yang S, Acosta M, et al. Treatment with neuraminidase inhibitors for critically ill patients with influenza A (H1N1)pdm09. Clin Infect Dis. 2012;55:1198–204. - PubMed
    1. Muthuri SG, Venkatesan S, Myles PR, et al. PRIDE Consortium Investigators Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data. Lancet Respir Med. 2014;2:395–404. - PMC - PubMed
    1. Harper SA, Bradley JS, Englund JA, et al. Expert Panel of the Infectious Diseases Society of America Seasonal influenza in adults and children—diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2009;48:1003–32. - PMC - PubMed

MeSH terms